20.17
전일 마감가:
$26.67
열려 있는:
$25.77
하루 거래량:
2.14M
Relative Volume:
1.32
시가총액:
$196.33M
수익:
-
순이익/손실:
$-121.02M
주가수익비율:
-1.7913
EPS:
-11.26
순현금흐름:
$-114.09M
1주 성능:
-12.42%
1개월 성능:
+146.58%
6개월 성능:
+38.15%
1년 성능:
-96.61%
토닉스 파마슈티컬스 홀딩 Stock (TNXP) Company Profile
명칭
Tonix Pharmaceuticals Holding Corp
전화
212-980-9155
주소
26 MAIN STREET, SUITE 101, CHATHAM, NY
TNXP을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
TNXP
Tonix Pharmaceuticals Holding Corp
|
20.17 | 196.33M | 0 | -121.02M | -114.09M | -11.26 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
토닉스 파마슈티컬스 홀딩 Stock (TNXP) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2022-04-18 | 개시 | Noble Capital Markets | Outperform |
2019-04-18 | 업그레이드 | ROTH Capital | Neutral → Buy |
2017-08-18 | 업그레이드 | ROTH Capital | Neutral → Buy |
2016-09-07 | 다운그레이드 | ROTH Capital | Buy → Neutral |
2016-02-17 | 재확인 | Oppenheimer | Outperform |
2015-11-04 | 개시 | Cantor Fitzgerald | Buy |
2015-06-12 | 개시 | Oppenheimer | Outperform |
2015-02-17 | 재확인 | ROTH Capital | Buy |
2014-09-29 | 재확인 | ROTH Capital | Buy |
모두보기
토닉스 파마슈티컬스 홀딩 주식(TNXP)의 최신 뉴스
(TNXP) Long Term Investment Analysis - Stock Traders Daily
Tonix Pharmaceuticals Announces Presentation at the - GlobeNewswire
Fast-Tracked Fibromyalgia Treatment: Tonix Showcases Breakthrough Pain Drug Data Before FDA Decision - StockTitan
Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting - Yahoo Finance
2 Stocks Riding the Biotech Surge With Major Catalysts Ahead - Investing.com
Tonix Pharmaceuticals: Potential To Have 'First' New Fibromyalgia Drug In 15 Years - Seeking Alpha
Noble Capital maintains Outperform on Tonix Pharma, $70 target By Investing.com - Investing.com South Africa
Noble Capital maintains Outperform on Tonix Pharma, $70 target - Investing.com
Tonix Pharmaceuticals: FDA AdCom News Positive, But Making Bull Case Is Problematic (TNXP) - Seeking Alpha
Pharma Frenzy: Volatility Ignites Biotech Sector - Benzinga
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
Tonix advances fibromyalgia drug, eyes Q4 2025 launch By Investing.com - Investing.com Australia
Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment; Shares Up - Marketscreener.com
Tonix advances fibromyalgia drug, eyes Q4 2025 launch - Investing.com India
Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment - Marketscreener.com
Tonix Pharmaceuticals stock soars on FDA update By Investing.com - Investing.com Australia
Tonix Pharmaceuticals stock soars on FDA update - Investing.com
Tonix Pharma’s TNX-102 SL Advances in FDA Process - TipRanks
Tonix Pharmaceuticals Announces that FDA Will Not Require - GlobeNewswire
First New Fibromyalgia Treatment in 15 Years Advances: FDA Expedites TNX-102 SL Review - StockTitan
Tonix Pharmaceuticals Stock Dives After Q4 Earnings Miss, But Retail’s Feeling Bullish - MSN
As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread - BioSpace
New Single-Dose Mpox Vaccine Outperforms Existing Options as Cases Surge Worldwide - StockTitan
Tonix Pharma stock drops after Q4 revenue miss (TNXP:NASDAQ) - Seeking Alpha
Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Tonix Pharmaceuticals Reports 2024 Financial Results and Pipeline Progress - TipRanks
Tonix Pharmaceuticals stock tumbles on earnings miss - Investing.com India
Tonix Pharma earnings missed by $5.86, revenue fell short of estimates - Investing.com
Tonix Pharmaceuticals stock tumbles on earnings miss By Investing.com - Investing.com Australia
Tonix Pharmaceuticals Holding Corp. SEC 10-K Report - TradingView
Tonix Pharmaceuticals 8-K Filing Analysis - TradingView
Tonix Pharmaceuticals Holding Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - GlobeNewswire
Tonix Secures Path to First New Fibromyalgia Drug in 15 Years with $98.8M War Chest - StockTitan
Learn to Evaluate (TNXP) using the Charts - Stock Traders Daily
* Tonix pharmaceuticals announces 1-for-10 reverse stock split - Reuters
Tonix Pharmaceuticals secures MCDC grant to advance next-gen Mpox & Smallpox vaccine development - Proactive Investors USA
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing - The Manila Times
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025 - GlobeNewswire
Major FDA Decision Looms: Tonix's Revolutionary Fibromyalgia Treatment Could End 15-Year Innovation Drought - StockTitan
Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target - BioSpace
Tonix's TNX-1500 Shows Promise in Preventing Organ Transplant Re - NEWS CHANNEL NEBRASKA
Clinical Trial Success: Tonix's New Drug Could Revolutionize $5.5B Transplant Market - StockTitan
Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week - MSN
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th - GlobeNewswire
Tonix Pharmaceuticals to Present at Zacks SCR Life Sciences Virtual Investor Forum - Nasdaq
Tonix Unveils FDA Timeline and Pipeline Progress: Live Q&A with CEO March 13 - StockTitan
Tonix Pharma Secures Grant for TNX-801 Vaccine Development - TipRanks
Tonix Pharmaceuticals receives MCDC grant for devloping its single-dose Mpox and Smallpox vaccine - Marketscreener.com
토닉스 파마슈티컬스 홀딩 (TNXP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):